Company: ADPT
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103752
Chunk: 47

Company: Adaptive Biotechnologies Corp
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 47
---
 | 265,225 |            |     | — |           |     |       — |                |     |       — |           |     |    — |           |     |         — |
|                     |     |            | 3/4/2024  |     | RSU        |     |                                      | — |           |     |       — |            |     | — |           |     | 175,000 |                |     |       — |           |     |    — |           |     |   698,250 |
|                     |     |            | 3/4/2024  |     | PSU(4)     |     |                                      | — |           |     |       — |            |     | — |           |     | 175,000 |                |     |       — |           |     |    — |           |     | 1,135,750 |

| * | Not applicable |

| (1) | Represents annual cash bonus incentives awarded in 2024, which are paid based on a weighted mix of individual and corporate performance objectives. Actual cash bonus incentives earned for 2024 are disclosed in the “Non-Equity Incentive Plan Compensation” column of the “Summary Compensation Table” table. |

| (2) | Target assumes 100% achievement of both individual and corporate performance objectives. Payouts may not exceed 125% of the target bonus except in extraordinary circumstances. |

| (3) | In accordance with SEC rules, amounts in this column reflect the aggregate grant date fair value of RSU, target number of PSU and stock option awards granted, as applicable, computed in accordance with ASC 718, rather than the amounts paid or realized by the named individual. We provide information regarding the assumptions used to calculate the grant date fair value of our RSUs, PSUs and stock options in Note 14 to our audited consolidated financial statements filed with our Annual Report on Form 10-K for the year ended December 31, 2024. |

| (4) | A description of the PSU award granted is provided above in the CD&A under “Executive Compensation Design and Philosophy.” The number of shares and the grant date fair value reflects the target number of PSUs awarded, but up to 200% of target shares may be earned. |

36

Option Exercises and Stock Vested The following table sets forth information regarding option exercises and stock award vesting events for our named executive officers for the year ended December